{
  "disease_name": "Ataxia-oculomotor apraxia type 1",
  "orpha_code": "1168",
  "drugs": [
    {
      "name": "Acetylleucine",
      "substance_url": "/en/drug/substance/479413?name=1168&mode=orpha&region=&status=all",
      "substance_id": "479413",
      "regulatory_url": "/en/drug/regulatory/673778?name=1168&mode=orpha&region=",
      "regulatory_id": "673778",
      "orpha_substance_code": "ORPHA:459033",
      "details": [
        "Acetylleucine(Medicinal product                        - 16/04/2024)Disease(s) concernedORPHA:1168 Ataxia-oculomotor apraxia type 1ORPHA:64753 Spinocerebellar ataxia with axonal neuropathy type 2ORPHA:459033 Ataxia-oculomotor apraxia type 4",
        "Acetylleucine(Medicinal product                        - 16/04/2024)",
        "(Medicinal product                        - 16/04/2024)",
        "Disease(s) concernedORPHA:1168 Ataxia-oculomotor apraxia type 1ORPHA:64753 Spinocerebellar ataxia with axonal neuropathy type 2ORPHA:459033 Ataxia-oculomotor apraxia type 4",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/479413?name=1168&mode=orpha&region=&status=all",
          "text": "Acetylleucine",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/1168",
          "text": "ORPHA:1168 Ataxia-oculomotor apraxia type 1",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/64753",
          "text": "ORPHA:64753 Spinocerebellar ataxia with axonal neuropathy type 2",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/459033",
          "text": "ORPHA:459033 Ataxia-oculomotor apraxia type 4",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/673778?name=1168&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US",
        "EU"
      ]
    },
    {
      "name": "Ceftriaxone",
      "substance_url": "/en/drug/substance/418160?name=1168&mode=orpha&region=&status=all",
      "substance_id": "418160",
      "regulatory_url": "/en/drug/regulatory/437311?name=1168&mode=orpha&region=",
      "regulatory_id": "437311",
      "orpha_substance_code": "ORPHA:247765",
      "details": [
        "Ceftriaxone(Medicinal product                        - 15/01/2015)Disease(s) concernedORPHA:99 Autosomal dominant cerebellar ataxiaORPHA:1172 Autosomal recessive cerebellar ataxiaORPHA:247765 X-linked cerebellar ataxia",
        "Ceftriaxone(Medicinal product                        - 15/01/2015)",
        "(Medicinal product                        - 15/01/2015)",
        "Disease(s) concernedORPHA:99 Autosomal dominant cerebellar ataxiaORPHA:1172 Autosomal recessive cerebellar ataxiaORPHA:247765 X-linked cerebellar ataxia",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/418160?name=1168&mode=orpha&region=&status=all",
          "text": "Ceftriaxone",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/99",
          "text": "ORPHA:99 Autosomal dominant cerebellar ataxia",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/1172",
          "text": "ORPHA:1172 Autosomal recessive cerebellar ataxia",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/247765",
          "text": "ORPHA:247765 X-linked cerebellar ataxia",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/437311?name=1168&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    }
  ],
  "processing_timestamp": "2025-07-07T06:01:59.558319",
  "run_number": 1,
  "total_drugs_found": 2,
  "search_url": "https://www.orpha.net/en/drug?diseaseName=Ataxia-oculomotor+apraxia+type+1&orphaCode=1168&name=1168&region=&mode=orpha&status=all",
  "search_params": {
    "diseaseName": "Ataxia-oculomotor apraxia type 1",
    "orphaCode": "1168",
    "name": "1168",
    "region": "",
    "mode": "orpha",
    "status": "all"
  }
}